• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于 COPD 高危人群气道阻塞诊断的肺功能检查:GOLD 和正常下限标准。

Spirometry for the diagnosis of airway obstruction in patients with risk factors for COPD: the GOLD and lower limit of normal criteria.

机构信息

. Departamento de Pneumologia, Hospital da Luz Lisboa, Lisboa, Portugal.

. Departamento de Matemática, Universidade de Aveiro, Aveiro, Portugal.

出版信息

J Bras Pneumol. 2022 Jan 7;47(6):e20210124. doi: 10.36416/1806-3756/e20210124. eCollection 2022.

DOI:10.36416/1806-3756/e20210124
PMID:35019054
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8836624/
Abstract

OBJECTIVE

The identification of persistent airway obstruction is key to making a diagnosis of COPD. The GOLD guidelines suggest a fixed criterion-a post-bronchodilator FEV1/FVC ratio < 70%-to define obstruction, although other guidelines suggest that a post-bronchodilator FEV1/FVC ratio < the lower limit of normal (LLN) is the most accurate criterion.

METHODS

This was an observational study of individuals ≥ 40 years of age with risk factors for COPD who were referred to our pulmonary function laboratory for spirometry. Respiratory symptoms were also recorded. We calculated the prevalence of airway obstruction and of no airway obstruction, according to the GOLD criterion (GOLD+ and GOLD-, respectively) and according to the LLN criterion (LLN+ and LLN-, respectively). We also evaluated the level of agreement between the two criteria.

RESULTS

A total of 241 individuals were included. Airway obstruction was identified according to the GOLD criterion in 42 individuals (17.4%) and according to the LLN criterion in 23 (9.5%). The overall level of agreement between the two criteria was good (k = 0.67; 95% CI: 0.52-0.81), although it was lower among the individuals ≥ 70 years of age (k = 0.42; 95% CI: 0.12-0.72). The proportion of obese individuals was lower in the GOLD+/LLN+ category than in the GOLD+/LLN- category (p = 0.03), as was the median DLCO (p = 0.04).

CONCLUSIONS

The use of the GOLD criterion appears to be associated with a higher prevalence of COPD. The agreement between the GOLD and LLN criteria also appears to be good, albeit weaker in older individuals. The use of different criteria to define airway obstruction seems to identify individuals with different characteristics. It is essential to understand the clinical meaning of discordance between such criteria. Until more data are available, we recommend a holistic, individualized approach to, as well as close follow-up of, patients with discordant results for airway obstruction.

摘要

目的

持续性气道阻塞的识别是 COPD 诊断的关键。GOLD 指南建议使用固定标准(支气管扩张剂后 FEV1/FVC 比值<70%)来定义阻塞,尽管其他指南认为支气管扩张剂后 FEV1/FVC 比值<正常下限(LLN)是最准确的标准。

方法

这是一项针对≥40 岁且有 COPD 风险因素的个体的观察性研究,这些个体被转诊到我们的肺功能实验室进行肺活量测定。还记录了呼吸症状。我们根据 GOLD 标准(分别为 GOLD+和 GOLD-)和 LLN 标准(分别为 LLN+和 LLN-)计算气道阻塞和无气道阻塞的患病率。我们还评估了这两个标准之间的一致性水平。

结果

共纳入 241 名个体。根据 GOLD 标准,42 名(17.4%)个体存在气道阻塞,根据 LLN 标准,23 名(9.5%)个体存在气道阻塞。两个标准之间的总体一致性水平较好(k=0.67;95%CI:0.52-0.81),但在≥70 岁的个体中较低(k=0.42;95%CI:0.12-0.72)。GOLD+/LLN+组肥胖个体的比例低于 GOLD+/LLN-组(p=0.03),DLCO 中位数也较低(p=0.04)。

结论

使用 GOLD 标准似乎与 COPD 的更高患病率相关。GOLD 和 LLN 标准之间的一致性似乎也很好,尽管在老年个体中较弱。使用不同的标准来定义气道阻塞似乎可以识别具有不同特征的个体。了解这些标准之间的差异具有重要意义。在有更多数据之前,我们建议对气道阻塞结果不一致的患者采取整体、个体化的方法,并进行密切随访。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea8e/8836624/7708038d9a8c/1806-3756-jbpneu-47-06-e20210124-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea8e/8836624/7708038d9a8c/1806-3756-jbpneu-47-06-e20210124-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea8e/8836624/7708038d9a8c/1806-3756-jbpneu-47-06-e20210124-gf1.jpg

相似文献

1
Spirometry for the diagnosis of airway obstruction in patients with risk factors for COPD: the GOLD and lower limit of normal criteria.用于 COPD 高危人群气道阻塞诊断的肺功能检查:GOLD 和正常下限标准。
J Bras Pneumol. 2022 Jan 7;47(6):e20210124. doi: 10.36416/1806-3756/e20210124. eCollection 2022.
2
Impacts of Different Spirometry Reference Equations and Diagnostic Criteria on the Frequency of Airway Obstruction in Adult People of North China.不同肺量计参考方程和诊断标准对华北地区成年人群气道阻塞频率的影响。
Int J Chron Obstruct Pulmon Dis. 2020 Mar 27;15:651-659. doi: 10.2147/COPD.S232863. eCollection 2020.
3
Clinical characteristics of patients newly diagnosed with COPD by the fixed ratio and lower limit of normal criteria: a cross-sectional analysis of the TargetCOPD trial.根据固定比例和正常标准下限新诊断为慢性阻塞性肺疾病(COPD)患者的临床特征:TargetCOPD试验的横断面分析
Int J Chron Obstruct Pulmon Dis. 2018 Jun 21;13:1979-1986. doi: 10.2147/COPD.S146914. eCollection 2018.
4
COPD in chronic heart failure: less common than previously thought?慢性心力衰竭合并 COPD:比以前认为的更少见?
Heart Lung. 2013 Sep-Oct;42(5):365-71. doi: 10.1016/j.hrtlng.2013.07.002.
5
Fixed Ratio versus Lower Limit of Normality for Diagnosing COPD in Primary Care: Long-Term Follow-Up of EGARPOC Study.固定比值与正常下限在初级保健中诊断 COPD 的比较:EGARPOC 研究的长期随访。
Int J Chron Obstruct Pulmon Dis. 2020 Jun 18;15:1403-1413. doi: 10.2147/COPD.S250720. eCollection 2020.
6
Lung function in Lolland-Falster Health Study (LOFUS).洛兰-法尔斯特健康研究中的肺功能(LOFUS)。
Clin Respir J. 2022 Oct;16(10):657-668. doi: 10.1111/crj.13536. Epub 2022 Sep 2.
7
Comparison of the prevalence of chronic obstructive pulmonary disease diagnosed by lower limit of normal and fixed ratio criteria.采用正常下限和固定比值标准诊断的慢性阻塞性肺疾病患病率比较。
J Korean Med Sci. 2009 Aug;24(4):621-6. doi: 10.3346/jkms.2009.24.4.621. Epub 2009 Jul 29.
8
Clinical impact of the lower limit of normal of FEV/FVC on detecting chronic obstructive pulmonary disease: A follow-up study based on cross-sectional data.FEV/FVC 下限对慢性阻塞性肺疾病检出的临床影响:基于横断面数据的随访研究。
Respir Med. 2018 Jun;139:27-33. doi: 10.1016/j.rmed.2018.04.011. Epub 2018 Apr 19.
9
Lung function decline in relation to diagnostic criteria for airflow obstruction in respiratory symptomatic subjects.与呼吸道症状患者气流阻塞诊断标准相关的肺功能下降。
BMC Pulm Med. 2012 Mar 22;12:12. doi: 10.1186/1471-2466-12-12.
10
Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review.诊断 COPD 时的正常值下限或 FEV1/FVC<0.70:基于证据的综述。
Respir Med. 2011 Jun;105(6):907-15. doi: 10.1016/j.rmed.2011.01.008. Epub 2011 Feb 5.

引用本文的文献

1
Estimating the global prevalence of chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis.估算慢性阻塞性肺疾病(COPD)的全球患病率:一项系统评价与荟萃分析
BMC Public Health. 2024 Jan 25;24(1):297. doi: 10.1186/s12889-024-17686-9.

本文引用的文献

1
Comparison of five major airflow limitation criteria to identify high-risk individuals with COPD: a contemporary population-based cohort.五种主要气流受限标准在识别 COPD 高危个体中的比较:一项当代基于人群的队列研究。
Thorax. 2020 Nov;75(11):944-954. doi: 10.1136/thoraxjnl-2020-214559. Epub 2020 Aug 20.
2
Assessment of comorbidities and prognosis in patients with COPD diagnosed with the fixed ratio and the lower limit of normal: a systematic review and meta-analysis.评估固定比值和正常下限诊断 COPD 患者的合并症和预后:系统评价和荟萃分析。
Respir Res. 2020 Jul 16;21(1):189. doi: 10.1186/s12931-020-01450-9.
3
Exercise Tolerance according to the Definition of Airflow Obstruction in Smokers.
根据吸烟者气流阻塞定义的运动耐量
Am J Respir Crit Care Med. 2020 Sep 1;202(5):760-762. doi: 10.1164/rccm.202002-0298LE.
4
Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement.肺功能测定标准化 2019 修订版。美国胸科学会和欧洲呼吸学会官方技术声明。
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88. doi: 10.1164/rccm.201908-1590ST.
5
Predictive value of prebronchodilator and postbronchodilator spirometry for COPD features and outcomes.支气管扩张剂使用前和使用后肺量计对慢性阻塞性肺疾病特征和预后的预测价值。
BMJ Open Respir Res. 2017 Dec 18;4(1):e000213. doi: 10.1136/bmjresp-2017-000213. eCollection 2017.
6
The impact of different spirometric definitions on the prevalence of airway obstruction and their association with respiratory symptoms.不同肺量计定义对气道阻塞患病率的影响及其与呼吸道症状的关联。
ERJ Open Res. 2017 Dec 8;3(4). doi: 10.1183/23120541.00110-2017. eCollection 2017 Oct.
7
2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung.2017 年ERS/ATS 肺一氧化碳单次呼吸摄取量标准。
Eur Respir J. 2017 Jan 3;49(1). doi: 10.1183/13993003.00016-2016. Print 2017 Jan.
8
Clinical relevance of diagnosing COPD by fixed ratio or lower limit of normal: a systematic review.通过固定比例或正常下限诊断慢性阻塞性肺疾病的临床相关性:一项系统评价
COPD. 2014 Feb;11(1):113-20. doi: 10.3109/15412555.2013.781996. Epub 2013 Jul 17.
9
Chronic obstructive pulmonary disease prevalence in Lisbon, Portugal: the burden of obstructive lung disease study.葡萄牙里斯本慢性阻塞性肺疾病患病率:阻塞性肺病负担研究
Rev Port Pneumol. 2013 May-Jun;19(3):96-105. doi: 10.1016/j.rppneu.2012.11.004. Epub 2013 May 8.
10
Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction.比较诊断吸烟相关气流阻塞的肺量计阈值。
Thorax. 2014 May;69(5):409-14. doi: 10.1136/thoraxjnl-2012-202810. Epub 2013 Mar 23.